Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. [electronic resource]
- British journal of cancer 07 2019
- 180-192 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1532-1827
10.1038/s41416-019-0492-8 doi
Adult Aged Body Height Body Mass Index Female Genes, BRCA1 Genes, BRCA2 Heterozygote Humans Mendelian Randomization Analysis Menopause Middle Aged Mutation Ovarian Neoplasms--etiology Proportional Hazards Models